Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
Hochman
Judith S
JS
Division of Cardiology, New York University School of Medicine, 550 First Ave, OBV-A632, New York, NY 10016-9196, USA. judith.hochman@med.nyu.edu
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D015897:Comorbidity; D003182:Complement C5 / Q000037:antagonists & inhibitors; D001026:Coronary Artery Bypass; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors / Q000378:metabolism; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D009204:Myocardial Revascularization; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D052247:Nitric Oxide Synthase Type II; D012770:Shock, Cardiogenic / Q000175:diagnosis* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis / Q000503:physiopathology
D003182:Complement C5; D004791:Enzyme Inhibitors; D018836:Inflammation Mediators; D009569:Nitric Oxide; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II